Hypofractionated proton beam therapy for localized prostate cancer
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000020199
- Lead Sponsor
- Aizawa hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 120
Not provided
1) With active other cancers 2) With severe uncontrolled diabetes 3) With severe heart disease, or some serious complications, i.e., SLE, Scleroderma, interstitial pneumonia 4) Allergic to radiation 5) Previous surgical treatment for prostate disease before enrollment 6) Previous chemotherapy (except holmonal therapy)for prostate cancer before enrollment 7) Previous radiotherapy to pelvis 8) With implantable cardioverter defibrillator or permanent pacemaker 9) Considered that participation in this trial is difficult because of psychiatric symptoms or psychosis 10) Cannot be held rest for about 60 minutes 11) Cannot be implanted Au marker in the prostate 12) Unsuitable for enrollment judged by principal investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 5-year rate of Grade 2 or worse late toxicity
- Secondary Outcome Measures
Name Time Method Acute and late toxicity rate, biochemical relapse-free rate, overall survival rate, cause-specific survival rate, and clinical relapse-free survival rate at 5 years